Novartis (REGD) Dividend yield




   CHF/share 
 Price  81.25
 Dividend  3.10
 Earnings  11.44
 Cash-flow  6.16
 Book value  28.02
 Equity  25.03

Novartis (REGD) is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Novartis (REGD) is a company from Switzerland, and his stocks are publicly traded.

Novartis (REGD) paid a total dividend of 6,929 million CHF last year, for a market value of 181,594 millions (Market Cap 170,403 millions). Dividend per share of Novartis (REGD) is 3.10 CHF, and his stock market price 81.25 CHF.

According to the chart below, where dividend yield is displayed, Novartis (REGD) has a dividend yield of 3.82%, which is higher than the amount offered by both the market average and companies from Switzerland. It is also bigger than average of Health Care industry. This high dividend yield might be a sign to worry about the future of the company so deeper analysis is needed.

In addition, you should compare Novartis (REGD) dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Switzerland.

Dividend yield of Novartis (REGD)

Novartis (REGD) Dividend Payout

About the ability of Novartis (REGD) to maintain his current dividend of CHF 3.10 per share, an amount that accounts for 3.82%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Novartis (REGD) payout on ernings is currently 27.10%, which is lower than the market average and companies of Health Care industry, which are 38.25% and 29.07% respectively. Both figures lead us to believe that there is confidence that Novartis (REGD)can maintain his current dividend.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Novartis (REGD) is CHF 6.16 per share, which is higher than the dividend per share paid by the company of CHF 3.10, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Novartis (REGD), compared againt world market average, Switzerland companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Novartis (REGD) payout

Novartis (REGD) Dividend History

Year Yield  CHF  Paypout  Shares* 
Present3.82%3.1027.10%2,235
20213.74%3.0061.22%2,205
20203.53%2.9568.76%2,289
20193.10%2.8540.31%2,241
20183.33%2.8058.33%2,318
20173.34%2.7558.76%2,364
20163.84%2.7032.69%2,514
20152.96%2.6050.58%2,369

*In millions

Novartis (REGD) Stock performance

Finally, last moth Novartis (REGD) showed a return of 1.10% compared to a worldwide 1.12% average, and a 1.32% of Health Care firms. Over the last year, the company obtained a 0.60% versus a worldwide performance of a 5.73%. More detailed information can be seen in the following graph for Switzerland and Pharmaceuticals and Biotechnology firms.

Novartis (REGD) stock and market return